Literature DB >> 8584480

Glycine crystallization during freezing: the effects of salt form, pH, and ionic strength.

M J Akers1, N Milton, S R Byrn, S L Nail.   

Abstract

PURPOSE: The purpose of the study is to characterize glycine crystallization during freezing of aqueous solutions as a function of the glycine salt form (i.e., neutral glycine, glycine hydrochloride, and sodium glycinate), pH, and ionic strength.
METHODS: Crystallization was studied by thermal analysis, microscopy, x-ray diffraction, and pulsed Fourier transform nmr spectroscopy.
RESULTS: A solution of neutral glycine with no additives undergoes rapid secondary crystallization during freezing, forming the beta polymorph, with a eutectic melting temperature of -3.4 degrees C. Glycine hydrochloride solutions undergo secondary crystallization relatively slowly, and the eutectic melting temperature is -28 degrees C. Sodium glycinate crystallizes from frozen solution at an intermediate rate, forming a eutectic mixture with a melting temperature of -17.8 degrees C. Where secondary crystallization does not occur rapidly, a complex glass transition is observed in the -70 degrees to -85 degrees C temperature range in the DSC thermograms of all systems studied. Rates of secondary crystallization and the type of crystal formed are influenced by solution pH relative the the pKs of glycine, and also by the change in ionic strength caused by adjustment of pH. Increased ionic strength significantly slows the crystallization of neutral glycine and promotes formation of the gamma polymorph. Thermal treatment or extended holding times during the freezing process may be necessary in order to promote secondary crystallization and prevent collapse during freeze drying.
CONCLUSIONS: The results underscore the importance of recognizing that seemingly minor changes in formulation conditions can have profound effects on the physical chemistry of freezing and freeze drying.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8584480     DOI: 10.1023/a:1016223101872

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

1.  Inhibition and reversal of aggregation of immunoglobulin G by freezing.

Authors:  U B Hansson
Journal:  Acta Chem Scand       Date:  1968

2.  Decreased protein-stabilizing effects of cryoprotectants due to crystallization.

Authors:  K Izutsu; S Yoshioka; T Terao
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

3.  Measurement of glass transition temperatures of freeze-concentrated solutes by differential scanning calorimetry.

Authors:  L M Her; S L Nail
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

4.  An improved microscope stage for direct observation of freezing and freeze drying.

Authors:  S L Nail; L M Her; C P Proffitt; L L Nail
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

5.  Electrolyte-induced changes in glass transition temperatures of freeze-concentrated solutes.

Authors:  L M Her; M Deras; S L Nail
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

6.  Effect of mannitol crystallinity on the stabilization of enzymes during freeze-drying.

Authors:  K Izutsu; S Yoshioka; T Terao
Journal:  Chem Pharm Bull (Tokyo)       Date:  1994-01       Impact factor: 1.645

7.  The effects of formulation variables on the stability of freeze-dried human growth hormone.

Authors:  M J Pikal; K M Dellerman; M L Roy; R M Riggin
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

  7 in total
  12 in total

1.  A new approach to explore the impact of freeze-thaw cycling on protein structure: hydrogen/deuterium exchange mass spectrometry (HX-MS).

Authors:  Aming Zhang; Wei Qi; Satish K Singh; Erik J Fernandez
Journal:  Pharm Res       Date:  2011-02-08       Impact factor: 4.200

2.  Optimization of the fine particle fraction of a lyophilized lysozyme formulation for dry powder inhalation.

Authors:  Sarah Claus; Claudius Weiler; Joerg Schiewe; Wolfgang Friess
Journal:  Pharm Res       Date:  2013-04-09       Impact factor: 4.200

3.  Thermophysical properties of pharmaceutically compatible buffers at sub-zero temperatures: implications for freeze-drying.

Authors:  Evgenyi Y Shalaev; Tiffany D Johnson-Elton; Liuquan Chang; Michael J Pikal
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

4.  Glycine crystallization in frozen and freeze-dried systems: effect of pH and buffer concentration.

Authors:  Dushyant B Varshney; Satyendra Kumar; Evgenyi Y Shalaev; Prakash Sundaramurthi; Shin-Woong Kang; Larry A Gatlin; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

5.  Phase transitions of glycine in frozen aqueous solutions and during freeze-drying.

Authors:  A Pyne; R Suryanarayanan
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

6.  Role of freeze-drying in the presence of mannitol on the echogenicity of echogenic liposomes.

Authors:  Krishna N Kumar; Sanku Mallik; Kausik Sarkar
Journal:  J Acoust Soc Am       Date:  2017-12       Impact factor: 1.840

7.  Solute crystallization in frozen systems-use of synchrotron radiation to improve sensitivity.

Authors:  Dushyant B Varshney; Satyendra Kumar; Evgenyi Y Shalaev; Shin-Woong Kang; Larry A Gatlin; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

8.  Physicochemical characterization of the freezing behavior of mannitol-human serum albumin formulations.

Authors:  Andrea Hawe; Wolfgang Friess
Journal:  AAPS PharmSciTech       Date:  2006       Impact factor: 3.246

9.  Phase transitions in frozen systems and during freeze-drying: quantification using synchrotron X-ray diffractometry.

Authors:  Dushyant B Varshney; Prakash Sundaramurthi; Satyendra Kumar; Evgenyi Y Shalaev; Shin-Woong Kang; Larry A Gatlin; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2009-03-27       Impact factor: 4.200

10.  Long-term stability of a vaccine formulated with the amphipol-trapped major outer membrane protein from Chlamydia trachomatis.

Authors:  H Eric Feinstein; Delia Tifrea; Guifeng Sun; Jean-Luc Popot; Luis M de la Maza; Melanie J Cocco
Journal:  J Membr Biol       Date:  2014-06-19       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.